Also trades as: GUD.TO (TSX) · $vol 1M
KHTRF OTC
Knight Therapeutics Inc.
1W: +4.0%
1M: +8.1%
3M: +8.1%
YTD: +71.7%
1Y: +69.0%
3Y: +106.3%
5Y: +73.7%
$7.47
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.0B
+8.5% ▲
5Y CAGR: +0.1%
Total Liabilities
$279M
+65.3% ▲
5Y CAGR: +12.7%
Shareholders Equity
$767M
-3.6% ▼
5Y CAGR: -2.9%
Cash & Investments
$95M
-44.9% ▼
5Y CAGR: -25.4%
Total Debt
$78M
+57.4% ▲
5Y CAGR: +6.7%
Net Debt
$1M
+104.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $86M | $72M | $59M | $80M | $76M |
| Short-Term Investments | $77M | $120M | $111M | $93M | $19M |
| Cash & ST Investments | $163M | $191M | $170M | $173M | $95M |
| Net Receivables | $67M | $95M | $89M | $114M | $138M |
| Inventory | $72M | $92M | $92M | $103M | $136M |
| Other Current Assets | $2M | $19M | $10M | $0 | $25M |
| Total Current Assets | $307M | $396M | $365M | $397M | $395M |
| Property, Plant & Equip. | $30M | $23M | $18M | $20M | $22M |
| Goodwill & Intangibles | $426M | $421M | $370M | $370M | $469M |
| Long-Term Investments | $179M | $158M | $120M | $103M | $124M |
| Other Non-Current Assets | $48M | $48M | $53M | $52M | $9M |
| Total Non-Current Assets | $685M | $659M | $580M | $567M | $651M |
| Total Assets | $992M | $1.1B | $945M | $964M | $1.0B |
| — Liabilities — | |||||
| Accounts Payable | $65M | $106M | $85M | $78M | $121M |
| Short-Term Debt | $27M | $18M | $18M | $17M | $20M |
| Deferred Revenue | $10M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $15M | $9M | $2M | $24M |
| Total Current Liabilities | $105M | $141M | $114M | $111M | $165M |
| Long-Term Debt | $9M | $52M | $44M | $26M | $51M |
| Other Non-Current Liab. | $20M | $26M | $32M | $24M | $53M |
| Total Non-Current Liabilities | $45M | $88M | $85M | $57M | $114M |
| Total Liabilities | $150M | $229M | $199M | $169M | $279M |
| — Equity — | |||||
| Common Stock | $629M | $599M | $540M | $534M | $530M |
| Retained Earnings | $192M | $162M | $151M | $155M | $149M |
| Accumulated OCI | -$376K | $41M | $30M | $80M | $56M |
| Total Stockholders Equity | $842M | $826M | $747M | $795M | $767M |
| Total Liabilities & Equity | $992M | $1.1B | $945M | $964M | $1.0B |
| — Key Metrics — | |||||
| Total Debt | $41M | $78M | $69M | $49M | $78M |
| Net Debt | -$45M | $6M | $10M | -$31M | $1M |
| Total Investments | $256M | $278M | $231M | $196M | $143M |